Cue Biopharma Inc CUE

‎$‎0.29620.01(4.92%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in Cue Biopharma Inc
Today

Create an eToro account to buy CUE stock on a secure, user-friendly, multi-asset trading platform.

Cue Biopharma Inc CUE

Buy CUE

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

AP Moeller - Maersk A/S

Reinet Investments SCA

MAX

*Past performance is not an indication of future results

Jump to:

About CUE >
How to Buy? >
Top Guides >

The Cue Biopharma Inc share price is stable this week.

The Cue Biopharma Inc share price today is ‎$‎0.2962, reflecting a ‎4.92‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of CUE is ‎$‎27.02M with an average volume in the last three months of 1.23M. The stock has a P/E ratio of -0.65 and a dividend yield of 0%. With the stock’s beta sitting at 1.28

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

CUE Key Metrics

Market Cap

‎$‎27.02M

Day’s Range

‎$‎0.27 - ‎$‎0.2984

52W Range

‎$‎0.2099 - ‎$‎1.95

Average Volume (3M)

1.23M

Price-Earnings Ratio

-0.65

Revenue

‎$‎7.1M

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎0.2962

EPS

‎$‎-0.46

Beta

1.28

How can I buy Cue Biopharma Inc stocks?

To purchase Cue Biopharma Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Cue Biopharma Inc (CUE) page and place an order to buy Cue Biopharma Inc.

Buy CUE

Looking for more information? Check out our guide on Academy.

What Is Cue Biopharma Inc?

Cue Biopharma Inc is a clinical-stage biotech company based in the United States that is pioneering a novel approach to cancer treatment. It develops injectable biologics designed to selectively activate a patient's own T cells, the immune system's soldiers, to directly attack cancer cells.

Operating in the healthcare sector, Cue Biopharma's targeted treatment approach aims to improve efficacy and minimise side effects compared to broad immune-modulating therapies. Its product pipeline includes a candidate that targets HPV-driven cancers like head and neck squamous cell carcinoma.

Stay up to date on the share price of CUE by adding it to your eToro watchlist.

CEO

Usman Azam, MD

Employees

Founded

2014

Boston, Massachusetts, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Cue Biopharma Inc
Today

Create an eToro account to buy CUE stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Cue Biopharma Inc stock?

The current price of CUE is ‎$‎0.2962.

What are analysts’ forecasts for Cue Biopharma Inc?

Analysts offer forecasts for Cue Biopharma Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Cue Biopharma Inc?

The market capitalisation of Cue Biopharma Inc is ‎$‎27.02M

Daily Movers

Explore the biggest stocks movers on the market.